During 1982-3, 31 specific and 12 uncharacterized infections were reported from 30 of 240 laboratories, representing 29 223 person-years of experience. Thirteen cases of hepatitis included 10 of type B or non-A, non-B hepatitis of probable occupational origin (attributable incidence 34.2 per 100 000 person years) affecting haematology, biochemistry, and postmortem workers. Of nine cases of tuberculosis, three were probably acquired in the laboratory (attributable incidence 10.3 per 100 000 person years) and affected microbiology, morbid anatomy, and postmortem staff. Microbiology staff also acquired, probably from the laboratory, four shigella infections and one each of brucella and herpes. The general community was the probable source of three cases of hepatitis A, two of rubella, and one of varicella. During the two years the risk of laboratory acquired infection mainly concerned the postmortem room and mortuary.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC499292PMC
http://dx.doi.org/10.1136/jcp.38.7.721DOI Listing

Publication Analysis

Top Keywords

cases hepatitis
8
attributable incidence
8
100 000
8
000 person
8
person years
8
acquired laboratory
8
infections british
4
british clinical
4
clinical laboratories
4
laboratories 1982-3
4

Similar Publications

AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals.

Gastroenterology

February 2025

Section of Gastroenterology and Hepatology, Veterans Affairs Northeast Ohio Health Care System, Cleveland, Ohio; Division of Gastroenterology and Hepatology, Case Western Reserve University, Cleveland, Ohio.

Background & Aims: Hepatitis B reactivation (HBVr) can occur due to a variety of immune-modulating exposures, including multiple drug classes and disease states. Antiviral prophylaxis can be effective in mitigating the risk of HBVr. In select cases, clinical monitoring without antiviral prophylaxis is sufficient for managing the risk of HBVr.

View Article and Find Full Text PDF

Effect of Hepatitis E Virus on the Male Reproductive System: A Review of Current Evidence.

Viruses

January 2025

Department of Biomedical & Nutritional Sciences, Zuckerberg College of Health Sciences, University of Massachusetts Lowell, Lowell, MA 01854, USA.

Hepatitis E Virus (HEV) is a globally widespread pathogen that causes acute hepatitis infection. Beyond hepatic pathogenesis, HEV has been proven to cause several extrahepatic manifestations, such as neurological, renal, and hematological manifestations. It was also associated with mortality in pregnant females.

View Article and Find Full Text PDF

Background: Hepatitis B (HBV) and Delta (HDV) virus infections pose critical public health challenges, particularly in Romania, where HDV co-infection is underdiagnosed.

Methods: This study investigates the epidemiology, risk factors, and clinical outcomes of HBV/HDV co-infection in vulnerable populations, leveraging data from the LIVE(RO2) program. Conducted between July 2021 and November 2023, the program screened 320,000 individuals across 24 counties, targeting socially disadvantaged groups such as rural residents, the Roma community, and those lacking health insurance.

View Article and Find Full Text PDF

Background: Psoriasis patients who are seropositive for hepatitis B surface antigen (HBsAg) or hepatitis B core antibody (HBcAb) face an elevated risk of hepatitis B virus reactivation (HBVr) when treated with cytokine inhibitors. This study aims to elucidate the risk in this population.

Methods: A retrospective chart review was conducted to assess the risk of HBVr in 73 psoriasis patients treated with cytokine inhibitors from 2013 to 2023.

View Article and Find Full Text PDF

Asian Perspective on Hepatitis B Virus and Hepatitis C Virus Elimination.

Viruses

December 2024

NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections remain significant public health challenges in Asia, affecting millions and contributing to substantial morbidity and mortality. The prevalence of these infections varies across the region, with factors such as vaccination coverage, healthcare infrastructure, and sociocultural barriers influencing the epidemiology of both viruses. The persistent burden of chronic HBV, particularly in older populations, and the evolving HCV genotype landscape highlight the need for targeted, region-specific strategies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!